Screener
Sabra Healthcare SBRA Debt Instrument Face Amount
Debt Instrument Face Amount at other companies
Other financials
Where this comes from
Reported directly by Sabra Healthcare in its filing.
Tagged under the XBRL concept us-gaap:LineOfCredit.
The source filing: Sabra Healthcare’s 10-Q, filed April 29, 2026.
- Filed
- Apr 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001492298-26-000012
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Total assets | $5,591,190 | $5,493,396 |
| Liabilities | ||
| Secured debt, net | $42,756 | $43,275 |
| Revolving credit facility | 354,979 | 217,584 |
| Term loans, net | 1,031,083 | 1,032,311 |
| Senior unsecured notes, net | 1,236,333 | 1,235,726 |
| Accounts payable and accrued liabilities | 117,947 | 119,329 |
| Lease intangible liabilities, net | 20,178 | 21,383 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Sabra Healthcare's debt instrument face amount?
- Sabra Healthcare (SBRA) reported debt instrument face amount of $354.98M in Q1 2026.
- How has Sabra Healthcare's debt instrument face amount changed year-over-year?
- Sabra Healthcare's debt instrument face amount increased by 329.3% year-over-year, from $82.68M to $354.98M.
- What does debt instrument face amount mean?
- This represents the total principal or par value of the company's outstanding debt instruments, excluding premiums or discounts. It provides a clear view of the total contractual debt obligations that must be repaid at maturity. This is a fundamental metric for calculating total leverage and assessing the company's overall debt burden.
Ask your AI about Sabra Healthcare's debt instrument face amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude